U.S. Insurance Stock News

Investors may be wondering whether Mechanics Bancorp remains attractively priced after its recent run or whether most of the value is already reflected in the share price. The stock closed at US$14.92, with a 1.3% return year to date, 70.5% over 1 year, a very large 3 year return and 166.7% over 5 years. Over shorter periods, the last 7 days show a 3.1% decline and the last 30 days a 1.4% gain. Recent coverage has focused on Mechanics Bancorp as a smaller regional bank that some investors...

Wellspect HealthCare, a subsidiary of DENTSPLY SIRONA (NasdaqGS:XRAY), has launched the Surity Male External Catheter in the U.S. The product expands Wellspect's non invasive continence care offering for people managing urinary incontinence. The launch reflects DENTSPLY SIRONA's efforts to broaden its presence in the continence care market beyond its core dental portfolio. DENTSPLY SIRONA is best known for its dental equipment and consumables, but Wellspect HealthCare gives the group...

Markets are being pulled in many directions right now, from energy shocks and stubborn inflation to shifting central bank policies and uneven growth signals across the US, Europe and Asia. When so many moving parts affect rates, currencies and input costs, it can help to anchor a portfolio in companies that our model scores as lower risk with resilient balance sheets. This Low-Risk Leaders screener focuses on stocks with the smallest risk scores in the tool, with the goal of reducing...

Coeur Mining (NYSE:CDE) has completed its acquisition of New Gold, reshaping its asset mix across gold, silver and copper. The company has updated and expanded its production guidance, including for 2026, reflecting the combined portfolio. Coeur has introduced its first dividend program and approved a $750 million share repurchase authorization. Coeur Mining operates a portfolio focused on precious metals, and the New Gold acquisition marks an expansion of that footprint, including entry...

Lanvin Group Holdings (NYSE:LANV) has opened FY 2025 with first half revenue of €133.4 million and a basic EPS loss of €0.62, setting a cautious tone for investors tracking its path toward profitability. Over the last three reporting halves, the company has seen revenue move from €170.98 million in 1H 2024 to €157.63 million in 2H 2024 and then to €133.4 million in 1H 2025. Over the same periods, basic EPS losses shifted from €0.49 to €0.92 and now €0.62, leaving margins under pressure and...

Boston Beer Company (SAM) opened 2026 with Q1 revenue of US$433.9 million and a basic EPS loss of US$13.88, setting a cautious tone for shareholders tracking both top line scale and per share profitability. Over the past year, quarterly revenue has moved within a band from US$385.7 million to US$587.9 million, while basic EPS has swung from a profit of US$5.45 in Q2 2025 to a loss in the most recent quarter, leaving trailing 12 month EPS at a loss of US$5.73. With the company currently...

NIP Group (NIPG) has just reported its FY 2025 first half results, with revenue of about US$61.2 million and a basic EPS loss of US$4.81, alongside a net loss of roughly US$136.0 million. The company has seen revenue move from about US$39.3 million in the first half of FY 2024 to US$45.9 million in the second half and then to US$61.2 million in the first half of FY 2025. Over the same periods, basic EPS has shifted from a loss of US$2.09 to a loss of US$0.16 and then to a loss of US$4.81,...

Q1 2026 earnings recap and setup DMC Global (BOOM) has posted Q1 2026 revenue of US$135.6 million with a basic EPS loss of US$0.30, while trailing twelve month revenue sits at US$586.1 million and EPS at a loss of US$1.23. Over recent quarters, revenue has moved from US$159.3 million in Q1 2025 through US$155.5 million, US$151.5 million and US$143.5 million to US$135.6 million in Q1 2026. Basic EPS shifted from a profit of US$0.04 to quarterly losses between US$0.10 and US$0.59, signaling...

Hippo Holdings (HIPO) opened 2026 with Q1 revenue of US$121.5 million and basic EPS of US$0.27, alongside trailing twelve month revenue of US$479.6 million and EPS of US$4.42. Over the past four reported quarters, revenue has moved from US$397.3 million to US$479.6 million on a trailing basis, while EPS shifted from a trailing loss of US$1.64 to EPS of US$4.42. This puts the focus on how durable that earnings profile really is. The latest quarter keeps attention squarely on margins and the...

Latest quarterly snapshot TFS Financial (TFSL) has just posted Q2 2026 results with total revenue of US$85.2 million and basic EPS of US$0.08, setting the tone for how investors will read the latest quarter. The company has seen revenue move from US$77.6 million in Q2 2025 to US$85.2 million in Q2 2026, while quarterly EPS has ranged between about US$0.07 and US$0.09 over the last six reported periods. This gives a clear view of how the top and bottom line have tracked together. With trailing...

Next Technology Holding (NasdaqCM:NXTT) opened 2026 with Q1 revenue of about US$0.5 million and a basic EPS loss of US$1.39 per share, alongside a net loss of US$105.9 million. Over recent quarters the company has seen revenue move from US$0 in Q1 2025 to US$9.8 million in Q4 2025 before landing at US$0.5 million in Q1 2026. EPS has swung from a very high profit of US$396.38 per share in Q1 2025 to a loss of US$1.39 in the latest quarter, setting a backdrop where reported margins look highly...

Wondering whether Blackbaud at around US$37.54 is a bargain or a value trap? This breakdown will help you size up what the current share price really reflects. The stock has been broadly flat over the last month at around 0.0%. However, that sits against a much tougher backdrop with a 36.9% decline year to date and a 38.9% decline over the past year. Those longer term returns mean many holders are sitting on losses, which often pushes valuation questions to the front of investors' minds...

Pro-Dex (PDEX) has put up a solid Q3 2026 print, with revenue of about US$19.9 million and basic EPS of roughly US$1.23, against a trailing twelve month backdrop where earnings grew 28.1% year over year and net profit margin sat at 16.1%. Over recent quarters the company has seen revenue move from around US$17.4 million in Q3 2025 to US$19.9 million in Q3 2026, while quarterly basic EPS ranged between roughly US$0.37 and US$1.43 over that stretch, giving a clear view of how revenue and per...

Jade Biosciences (NasdaqCM: JBIO) appointed Edward R. Conner, M.D. as Chief Medical Officer. The company elevated Andrew King, M.D., Ph.D. to President, Research & Development. These leadership changes focus on clinical development, regulatory strategy, and R&D continuity for Jade's autoimmune pipeline. Jade Biosciences, listed on NasdaqCM under the ticker JBIO, is focused on developing therapies for autoimmune conditions, an area that continues to attract capital and partnerships across...

Wondering if American Healthcare REIT is reasonably priced at around US$50 a share, or if the market is getting ahead of itself? This article walks through what the current numbers actually say about value. The stock recently closed at US$50.15, with returns of 0.1% over 7 days, 5.5% over 30 days, 6.2% year to date and 57.7% over the past year. This naturally raises questions about how much of the story is already reflected in the price. Recent coverage has focused on American Healthcare...

Structure Therapeutics (NasdaqGM:GPCR) plans multiple presentations at the 86th American Diabetes Association Scientific Sessions. The company will share new safety, efficacy, and dosing data for its oral GLP-1 receptor agonist aleniglipron. Additional data will cover a novel amylin receptor agonist combination, including findings on weight loss effects. The presentations focus on combination approaches in obesity and diabetes treatment development. Structure Therapeutics focuses on oral...

Clorox, NYSE:CLX, has completed its acquisition of GOJO Industries, the owner of the Purell brand. The deal adds a broad health and hygiene portfolio to Clorox's existing cleaning and household products. This transaction reflects a move to broaden Clorox's exposure beyond traditional household categories. Clorox enters this deal with its shares at $96.44, after a 27.3% decline over the past year and a 38.1% decline over the past five years. The acquisition of GOJO and Purell gives the...

St. Joe (JOE) opened 2026 with Q1 revenue of US$99 million and basic EPS of US$0.24, compared with Q1 2025 revenue of US$94 million and EPS of US$0.30. Trailing twelve month EPS stood at US$1.94 on revenue of US$518 million. Over that same twelve month stretch, net income reached US$112 million, giving investors a fuller view of how quarterly earnings feed into the broader profit picture. With a net margin of 21.6% over the last year, the latest numbers keep the spotlight firmly on how...

If you are wondering whether Meritage Homes at around US$67.34 is a bargain or just fairly priced, this breakdown will help you frame what the current share price might actually be offering you. The stock has recently been choppy, with a 3.7% decline over the last 7 days, an 8.9% gain over the past 30 days, and returns of 1.7% year to date and 3.2% over the last year. Recent coverage has focused on how Meritage Homes fits into the broader US homebuilding sector, with attention on its ability...

If you are wondering whether Centessa Pharmaceuticals at around US$39.42 is still offering value after its surge, you are asking the right question for this stock. The share price has delivered a 66.4% return year to date and 192.0% over the last year, with the 3 year return described as very large, even though the last 30 days have seen a small 0.8% decline and the last week has been flat at 0.0%. Recent coverage has focused on Centessa Pharmaceuticals as a higher growth biotech name, and...

XP Inc. (NasdaqGS:XP) released its audited 2025 annual results, giving investors a detailed view of the company’s most recent financial year. The company announced a new cash dividend, signaling a direct return of capital to shareholders. XP also launched a fresh share repurchase program and reported significant ownership positions held by institutional investors. XP operates as a financial services platform, connecting retail and institutional clients to investment products and advisory...

Shareholders of Generac Holdings Inc. ( NYSE:GNRC ) will be pleased this week, given that the stock price is up 19% to...

This article considers whether NIQ Global Intelligence, at around US$10.93, offers value or simply appears cheap on the surface by examining what the current price might really imply. The share price has eased back recently, with a 7‑day return of a 2.6% decline, a 30‑day return of a 3.9% decline, and a year‑to‑date return of a 30.7% decline. Recent coverage has focused on the stock's weaker near‑term returns and what they might signal about investor expectations, which helps explain why...

Investors may be wondering if Celanese is still attractively priced after its recent run, or if most of the value story is already reflected in the share price. The stock last closed at US$67.76, with returns of 3.9% over the past week, 3.0% over the past month, 60.7% year to date, and 49.6% over the past year, set against longer term returns of negative 30.6% over three years and negative 56.5% over five years. Recent coverage has focused on Celanese's position in the chemicals sector and...